Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis G. DésaméricqF. SchurhoffP. Maison Review Article 22 October 2013 Pages: 127 - 134
Putative effects of potentially anti-angiogenic drugs in rheumatic diseases Nicola MaruottiFrancesco Paolo CantatoreDomenico Ribatti Review Article 07 November 2013 Pages: 135 - 140
The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects Yi DingYanYan JiaAiDong Wen Clinical Trial 30 October 2013 Pages: 141 - 146
Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension Rodrigo C. SantosAna Paula C. de FariaHeitor Moreno Clinical Trial 24 November 2013 Pages: 147 - 154
Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients Sin-Chi ChewJoanne LimBalram Chowbay Pharmacogenetics 06 November 2013 Pages: 155 - 166
Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data Anna NordmarkAnita AnderssonLars Ståhle Pharmacokinetics and Disposition 02 November 2013 Pages: 167 - 178
Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients—nonlinear mixed effects modelling approach Branka BrzakovićKatarina VučićevićMilena Pokrajac Pharmacokinetics and Disposition 19 November 2013 Pages: 179 - 185
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy Concetta RafanielloFlavia LombardoAnnalisa Capuano Pharmacoepidemiology and Prescription 22 October 2013 Pages: 187 - 195
Factors associated with pregabalin dispensing at higher than the approved maximum dose Robert BodénBjörn WettermarkHelle Kieler Pharmacoepidemiology and Prescription 19 October 2013 Pages: 197 - 204
Use of exenatide and liraglutide in Denmark: a drug utilization study Anton PottegårdBine Kjøller BjerregaardSøren Ilsøe Moreno Pharmacoepidemiology and Prescription 22 October 2013 Pages: 205 - 214
Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug–drug interactions Emmanuel EschmannPatrick E. BeelerJürg Blaser Pharmacoepidemiology and Prescription 23 October 2013 Pages: 215 - 223
Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis Zexing WangJing XuXiaoxiang Guan Pharmacoepidemiology and Prescription 23 October 2013 Pages: 225 - 231
The influence of comprehensive geriatric assessment on drug therapy in elderly patients Michael Due LarsenJens Ulrik RosholmJesper Hallas Pharmacoepidemiology and Prescription 06 November 2013 Pages: 233 - 239
Long-term use of antiplatelet drugs by patients with transient ischaemic attack Kamilla ØstergaardCharlotte MadsenDavid Gaist Pharmacoepidemiology and Prescription 19 November 2013 Pages: 241 - 248
Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs Amelia TroncosoEduard Diogène Letter to the Editors 17 October 2013 Pages: 249 - 250
Cluster-like headache attacks triggered by nitrofurantoin intake Ilaria CasettaJay Guido Capone Letter to the Editors 22 October 2013 Pages: 251 - 252
